Advertisement
Advertisement
Trending on Urology Times
1
Choosing salvage therapy after prostate cancer focal ablation
2
Laura Bukavina, MD, highlights promise of EV/pembro and remaining questions on bladder preservation
3
NDV-01 produces robust 9-month results in high-risk NMIBC
4
Cretostimogene demonstrates safety, efficacy in papillary NMIBC cohort
5
